Company intelligence / Profile preview

Pappas Capital

Durham, North Carolina, United Statespappas-capital.com ↗

Ownership: Private
Development stage: Other

Overview

Pappas Capital has invested in over one hundred life science companies globally. Their investments have led to multiple successful IPOs and acquisitions. Portfolio products address significant unmet needs across oncology, neurology, infectious disease and rare disorders.

Therapeutic areas: OncologyPulmonologyNeurologyInfectious Diseases
Modalities: Small moleculeGene therapy (AAV gene medicines)Protein therapeuticsAntibodyRadiopharmaceuticalMedical device
Industry: Investors

Partnerships

Extensive partnerships with academic institutions for translational medicine initiatives.Portfolio company partnerships include major pharma collaborations but not directly at the VC level.

Beyond the preview

Go deeper on Pappas Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pappas Capital.

Explore the full profile